Skip to content
ppharmaranks
Menu
Class IIIOngoing

Verapamil Hydrochloride Injection recall

FDA recall D-0592-2024 · initiated Jul 2, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jul 17, 2024How we research

Zydus Pharmaceuticals (USA) Inc recalled Verapamil Hydrochloride Injection in Jul 2024 — an FDA Class III recall (D-0592-2024) because Cross contamination with other products.

Unlikely to cause harm but violates FDA labeling or manufacturing regulations.

Why it was recalled

Cross contamination with other products.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot# (a) Lots L300255, L300262, Exp Date 07/31/2025; (b)L300263, Exp Date 08/31/2025

Quantity recalled: 170,755 vials

Details

Product
Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-7; (b) 5x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-5; Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534,
Recalling company
Zydus Pharms
Classification
Class III
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Jul 2, 2024
FDA report date
Jul 17, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Verapamil Hydrochloride Injection recalled?
Zydus Pharmaceuticals (USA) Inc recalled Verapamil Hydrochloride Injection in Jul 2024 — an FDA Class III recall (D-0592-2024) because Cross contamination with other products. Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
Why was Verapamil Hydrochloride Injection recalled?
Per the FDA enforcement record, the reason for recall D-0592-2024 was: Cross contamination with other products.
Is a recalled Verapamil Hydrochloride Injection dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Unlikely to cause harm but violates FDA labeling or manufacturing regulations. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Verapamil Hydrochloride Injection are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lot# (a) Lots L300255, L300262, Exp Date 07/31/2025; (b)L300263, Exp Date 08/31/2025. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0592-2024.

Source: openFDA Drug Enforcement record D-0592-2024

← All drug recalls